490 likes | 703 Views
Psychopharmacology in Children. Irving Kuo M.D. Central Arkansas Veterans Healthcare System. Psychopharmacology requires a sense of humor. Sometimes, the best use of evidence-based medicine is to remember how little evidence we have. TA Kramer M.D. Psychopharmacology is big business.
E N D
Psychopharmacology in Children Irving Kuo M.D. Central Arkansas Veterans Healthcare System
Psychopharmacology requires a sense of humor. Sometimes, the best use of evidence-based medicine is to remember how little evidence we have. TA Kramer M.D.
Psychiatric Medication Use - Antidepressants • Antidepressants prescriptions: 1988 – 40 million 1998 – 120 million 2004 – 150 million • Antidepressant revenues 1986 - $263 million 2004 - $11.2 billion
Psychiatric Medication Use - Antipsychotics • Revenues: 1986 - $263 million 2004 - $8.6 billion • For last quarter of 2005 – 4/5 drugs that Arkansas Medicaid paid most for were for antipsychotic meds
Psychiatric Medication Use – ADHD Medications • 2.5 million children and 1.5 million adults prescribed these meds (2005) • $3.5 billion in revenues for 2005 • Marked increase in prescription since 1999 – advent of new formulations
Psychiatric Medication Use - Depakote • $886 million dollar sales last year • Leader in prescriptions for bipolar disorder
The Developing Brain • Most brain cells (neurons) are formed by the 2nd trimester in the fetus. • Neuronal migration (movement of neurons to their correct location) begins within weeks of conception. • Brain volume is at 95% of adult volume by age 5.
The Developing Brain • Neurons transmit signals electrically and chemically through synapses. • Neurons ondergo myelinization (insulation) and arborization (branching out) - continue throughout childhood and into adolescence/early adulthood. • Synapse formation continues throughout ones lifetime
The Developing Brain • Neurons that are created at birth must be the right ones. • Neurons must migrate to the right parts of the brain – orchestrated traffic. • Synapses must form once neurons are correctly placed.
The Developing Brain • Neurons and their synapses are quite changeable or “plastic” – neuroplasticity. • Neurons kill/prune themselves – apoptosis. • Up to 90% of neurons made during fetal development undergo apoptosis. • Apoptitic neurons “fade away” – the body removes sick/damaged cells – survival of the fittest.
The Developing Brain • At age 6 – more synapses than at any other time. • As children grow older – the brain prunes away half of all synaptic connections. • Hopefully, the body chooses well which synapses to keep and which ones to destroy. • New synapses form and are pruned throughout adulthood at a much slower rate
Children are not small adults in how their body handles drugs.
As little evidence as there is for psychopharmacology in adults, there’s much less for children.
Antidepressants - SSRIs • Prozac (fluoxetine) • Paxil (paroxetine) • Zoloft (sertraline) • Luvox (fluvoxamine) • Celexa (citalopram) • Lexapro (escitalopram)
Antidepressants - SSRIs • Selective serotonin reuptake inhibitors – increase serotonin available in synapse • Takes 2-4 weeks to begin to work • Used for depression and anxiety disorders (OCD, panic disorder, PTSD, social phobia) • Used for eating disorders, especially bulimia nervosa
Antidepressants – SSRIsHow well do they work? • In ideal studies – 2/3 patients responded • Response vs. remission • In more “real world” studies – 30% remission rate in adults • Only Prozac is approved by FDA for depression in children • Prozac, Luvox and Zoloft FDA-approved for OCD
Antidepressants – SSRIsHow well do they work? • Research indicate mixed results in children – some studies show a modest improvement in depressive symptoms, others show no difference when compared to placebo (sugar pill) • British study in 2004 – pooled available studies and indicated little to no improvement in children compared to placebo
Antidepressants – SSRIsPharmocokinetic Differences • Paxil cleared in children ages 6-17 faster than in adults, although once a day dosing is still recommended. • Prozac serum levels were almost twice as high in children than adolescents/adults with same dose – decrease dose for kids
Antidepressants – SSRIAdverse events • Behavioral activation in children – anxiety, restlessness or agitation • Possible switch to mania if patient is really bipolar • Amotivational syndrome • Possible bleeding complications – easy bruisability
Antidepressants and Suicide in Children • In 2004, the FDA looked at 24 clinical trial involving 4,400 children and adolescents taking antidepressants for depression and anxiety disorders. • Children taking active meds – 4% developed suicidal thoughts/behaviors • Children taking placebo – 2% • No children in studies committed suicide.
Antidepressants and Suicide in Children • This led to the FDA “black box” warning on package inserts about a possible link between antidepressants and onset of suicide behavior. • Possible explanations: - behavioral activation - manic switch - patient getting better in terms of energy but not mood
Antidepressants and Suicide in Children – Conclusions? • Antidepressants do help some children – the actual suicide rate in children/adolescents has decreased since the advent of SSRIs. • Close monitoring is a must for those on antidepressants – especially initially. • Medications should be only a part of a comprehensive treatment plan.
Atypical Antipsychotics • Clozaril (clozapine) – not much in kids • Risperdal (risperidone) • Zyprexa (olanzapine) • Seroquel (quetiapine) • Geodon (ziprasidone) • Abilify (aripiprazole)
Atypical Antipsychotics – Indications/Uses • Psychosis • Disorganized behavior • Bipolar disorder • Tics • More controversial but increasing: • ADHD • Conduct disorder • Pretty much any behavior we don’t like
Atypical Antipsychotics – Indications/Uses • Recent Vanderbilt University study – 5-fold increase in antipsychotic use in children for ADHD • Feeling among prescribers that atypicals are safer than the old generation antipsychotics • Don’t have the neurologic side effects of typical agents (or less frequent)
Atypical Antipsychotics – Mechanism of Action • Block dopamine receptors – antipsychotic action • Block serotonin receptors – prevent extrapyramidal side effects, reduce negative symtoms of schizophrenia • Pharmacokinetics have not been studied in children very much – seems to be similar to adults
Atypical Antipsychotics – Adverse Effects • Extrapyramidal effects - acute dystonic reaction - akathesia (restlessness) - Parkinson-like symptoms • Tardive dyskinesia • These are less common in the atypical antipsychotics but still possible
Atypical Antipsychotics –Adverse Effects • Weight gain/obesity • Increase blood sugar (diabetes) • Increase lipids (cholesterol/triglyceride levels) • Sedation • Increase prolactin levels – amenorrhea, galactorrhea, breast enlargement (males) • Cardiovascular - arrhythmias
Atypical Antipsychotics – Conclusions? • Effective in treatment of psychosis, tics, and behavioral problems where nothing else helps (i.e. developmental disorders) • Increasing use in ADHD and conduct disorders without basis in literature • Side-effects are not trivial – weight gain, metabolic – in a population where obesity is an increasing problem • Neurological side-effects still possible – who know what are the long-term CNS impact on kids
ADHD Medications – stimulants • Ritalin, Concerta (methylphenidate) • Dexedrine (dextroamphetamine) • Adderall (mixed amphetamine salts)
ADHD Medications – stimulantsMechanism of Action • Effect dopamine (DA) and norepiniphrine (NE) in the frontal lobes and other parts of the brain • Increase release of DA and NE in neurons • Block reuptake of DA and NE • Basically increase DA concentration in synapses
ADHD Medications – stimulants • Numerous studies point to significant efficacy over placebo in treatment of ADHD – in children and now in adults • Rate of prescriptions for children is actually leveling off, but increasing for adults (adult ADHD) – 140% increase from 2004 to 2005
ADHD Medications – stimulantsPharmacokinetics • Immediate release stimulants are rapidly absorbed by the gut – this can be increased by food • Immediate release stimulants begin to act 30 minutes after ingestion and effect last 3-5 hours • Recent introduction of long-acting stimulants with delayed delivery system – once a day dosing
ADHD Medications – stimulantsAdverse Events • Sleep problems • Decreased appetite • Jitteriness • Headache • Cardiovascular effects
ADHD Medications – stimulantsCardiovascular effects • February 9, 2006 – FDA voted to have “black box” warnings added to labeling of stimulants warning about the cardiovascular risks of stimulants • Sudden heart failure seen in children • Concern that adults with preexisting cardiac problems could be at increased risk when taking stimulants
ADHD Medications – stimulantsCardiovascular effects • Increase heart rate and blood pressure • Committee feeling that stimulant prescribing needed to be “slowed down.” • Fear surrounding increased utilization in adults
ADHD Medications – StimulantsConclusions? • Effective in treating ADHD – both in children and adults • Side-effects are not trivial • Monitoring of BP and heart rate as well as baseline and follow-up EKGs
Mood Stabilizers • Lithium • Depakote (sodium valproate) • Tegretol (carbamazepine) • Topomax (topirimate) • Lamictal (lamotrigine)
Mood Stabilizers – Depakote Indications/Uses • Anticonvulsant – adults and children > 10yo • Bipolar disorder • Migraine headaches – adults • Behavioral problems in adults and kids secondary to brain damage • PTSD
Mood Stabilizers - Depakote • Most frequently prescribed medication used for bipolar disorder • Increasing pediatric use for mood and behavioral control – impulsive and aggressive behaviors • Increase GABA in brain – inhibitory effects
Mood Stabilizers – DepakotePharmacokinetics • After absorption (slowed by food), reaches peak blood level in 3 hours • Half life in children – 7 hours • Half life in adults – 13 hours • Liver metabolism – kids under 10 yo have 50% greater clearance than in adolescents/adults • Multiple drug-drug interactions
Mood Stabilizers – DepakoteAdverse Events • GI effects – nausea, vomiting, indigestion – can improve with food • Weight gain/increased appetite • Neurological – tremor, sedation, cognitive slowing, ataxia – may be dose related • Decrease platelets in blood – increase bleeding • Acute pancreatitis – rare • Hair loss
Mood Stabilizers – DepakoteLiver toxicity • Fatal liver failure seen – 29/1,000,000 patients between 1987-1993 • Highest risk at age 2 or younger • High risk in children with mental retardation, receiving other anticonvulsants, or are developmentally delayed • Not indicated in children < 10 yo
Mood Stabilizers – DepakoteConclusions? • Lots of experience with kids since it was used as a seizure med in the pediatric population • Effective in adult bipolar disorder • Used off-label in kids – can be effective for aggressive/impulsive behaviors • Multiple side effects – tough med to take • Not for kids under 10 yo because of potential fatal liver problems
Psych Meds in KidsConclusions? • Very little supportive evidence for efficacy (except stimulants in ADHD) • Many known side-effects • Unknown effects – long term on the developing brain and body • Overused? – recent study of child psychiatrists show that 9/10 of their patients are on meds • Need much more than meds to help kids